Why Are South Asians Missing From Global Health Databases, Pg II
South Asians are critically underrepresented in global health databases, leading to biased AI/ML tools and inaccurate healthcare for diseases like diabetes, demanding urgent data diversity.
Over one in ten adults globally live with diabetes, with South Asians facing a higher and earlier risk.
Less than 1% of participants in global Genome-Wide Association Studies (GWAS) are of South Asian ancestry, despite comprising over 20% of the world's population.
This lack of diversity in health databases, including U.K. Biobank, leads to less accurate diagnostic tools and treatments for South Asian populations.
Initiatives like the GenomeIndia Project aim to address this gap by building comprehensive genetic databases for the region.
Detailed Insights:
The underrepresentation of South Asians in genomic and health datasets hinders the effectiveness of AI and machine learning tools in healthcare.
Polygenic risk scores, which estimate genetic disease risk, are less accurate for South Asians when developed using predominantly European data.
Diagnostic thresholds and prediction models developed from European populations often require recalibration for South Asian populations due to genetic variations.
South Asia exhibits immense genetic diversity, with significant differences even within countries like India, making a "one-size-fits-all" approach ineffective.
Historical funding disparities have led to inadequate research infrastructure and biobanking facilities in low- and middle-income countries.
Regional collaborations among existing biobanks and cohorts are proposed to build a robust data infrastructure and ensure equitable scientific benefits.
Scientific/Technical Concepts Involved:
Biobanks: Repositories storing biological samples and associated health data for research.
Genomic Data: Information derived from an organism's complete set of DNA, including genetic variants.
Polygenic Risk Scores: A measure combining the effects of multiple genetic variants to estimate an individual's risk for a disease.
Genome-Wide Association Studies (GWAS): An observational study of a genome-wide set of genetic variants in different individuals to see if any variant is associated with a trait.